Lexicon Pharmaceuticals Stock Options


USD 2.14  0.12  5.31%   

Lexicon Pharmaceuticals' option chain provides insight into all available option contracts written on Lexicon Pharmaceuticals' stock. Investors can see outstanding put and call contracts with pricing information and greeks for a given expiration period. In addition, each of Lexicon Pharmaceuticals' stock options below provides a detailed picture of the payoff. Comparing vital and dynamic information of various option contracts across diverse expiration periods will help you make an educated decision on your market timing strategies around investing in a given Lexicon option contract. View S&P 500 options
Purchasing Lexicon Pharmaceuticals options can give investors a meaningful hedge against losses and, therefore, could be used conservatively to decrease the volatility of your portfolio. However, many options could also amount to little more than gambling, significantly enhancing your overall portfolio risk. One simple example of these aggressive strategies is the sale of "uncovered" Lexicon calls. Remember, the seller must deliver Lexicon Pharmaceuticals stock to the call owner when a call is exercised.

In The Money vs. Out of Money Option Contracts on Lexicon Pharmaceuticals

Analyzing Lexicon Pharmaceuticals' in-the-money options over time can help investors to take a profitable long position in Lexicon Pharmaceuticals regardless of its overall volatility. This is especially true when Lexicon Pharmaceuticals' options are deep in the money. These options can be identified using deltas that are over 0.75. Deep in-the-money Lexicon Pharmaceuticals' options could be used as guardians of the underlying stock as they move almost dollar for dollar with Lexicon Pharmaceuticals' stock while costing only a fraction of its price.
Lexicon Pharmaceuticals' latest option contracts expiring on 2022-12-16 are carrying combined implied volatility of 195.56 with a put-to-call open interest ratio of 0.08 over 10 outstanding agreements suggesting investors are buying way more calls than puts on contracts expiring on 2022-12-16. The current put volume is at 59, with calls trading at the volume of 36. This yields a 1.64 put-to-call volume ratio. The Lexicon Pharmaceuticals option chain provides detailed quote and price information for the current Lexicon Pharmaceuticals option contracts. It shows all of Lexicon Pharmaceuticals' listed puts, calls, expiration dates, strike prices, and other pricing information.

Open Interest Against 2022-12-16 Option Contracts

Lexicon Pharmaceuticals option prices can potentially be used to forecast stock returns because most option chains provide information not only about the current prices but also about the future conditions in Lexicon Pharmaceuticals' lending market. For example, when Lexicon Pharmaceuticals' puts are not actively trading or completely missing in the marketplace, investors can use it to internalize expected shorting costs. So if an investor is writing a put option on Lexicon Pharmaceuticals, he or she must hedge the risk by shorting Lexicon Pharmaceuticals stock over its option's life.
The chart above shows Lexicon Pharmaceuticals' distribution of open interest by maturity on contracts that have not yet been settled. The area between the two highest points is the projection of the price at expiration. Lexicon Pharmaceuticals' open interest chart also provides vital information regarding the liquidity of an option. If there is no open interest for Lexicon Pharmaceuticals' option, there is no secondary market available for investors to trade.
Lexicon Pharmaceuticals' stock options are financial instruments that give investors the right to buy or sell shares of Lexicon Pharmaceuticals common stock at a specified price for a given time period. Generally speaking, an option to purchase or sell Lexicon stock makes it part of the underlying stock when the option's price is tied to the movement of the underlying stock. If Lexicon Pharmaceuticals' stock price goes up or down, the stock options follow.
Additionally, see Correlation Analysis.
Please note that buying 'in-the-money' options on Lexicon Pharmaceuticals lessens the impact of time decay, as they carry both intrinsic and time value. So, even if Lexicon Pharmaceuticals' value remains static through the expiration date, the investor can sell to close an 'in-the-money' option to avoid a potential loss. However, in-the-money Lexicon Pharmaceuticals contracts are usually more expensive to enter than their out-of-the-money counterparts. So keep in mind that while the payoffs on an in-the-money trade can be high, the investors could ultimately experience a more consequential loss if Lexicon Stock moves the wrong way.
Net Income Common Stock is likely to drop to about (94.7 M) in 2022

Lexicon Current Options Market Mood

Lexicon Pharmaceuticals' open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Lexicon Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.

Put-to-Call Open Interest

Put-to-Call Volume

Most options investors, including buyers and sellers of Lexicon Pharmaceuticals' calls and puts, are not very successful. It is estimated that an average options trader loses somewhere between 80% to 90% of the time. Lexicon Pharmaceuticals' option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction. Using current Lexicon Pharmaceuticals' option volume and open interest to make an investment decision is considered a contrarian-sentiment measure that can be utilized in many timing strategies in both derivative and spot marketplace.

Rule 16 of the current Lexicon contract

Base on the Rule 16, the options market is currently suggesting that Lexicon Pharmaceuticals will have an average daily up or down price movement of about 12.22% per day over the life of the 2022-12-16 option contract. With Lexicon Pharmaceuticals trading at USD2.14, that is roughly USD0.26. If you think that the market is fully incorporating Lexicon Pharmaceuticals' daily price movement you should consider buying Lexicon Pharmaceuticals options at the current volatility level of 195.56%. But if you have an opposite viewpoint you should avoid it and even consider selling them.

Lexicon Pharmaceuticals Option Chain

When Lexicon Pharmaceuticals' strike price is surpassing the current stock price, the option contract against Lexicon Pharmaceuticals stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
Lexicon Pharmaceuticals' option chain is a display of a range of information that helps investors for ways to trade options on Lexicon. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Lexicon. It also shows strike prices and maturity days for a Lexicon Pharmaceuticals against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone.
DeltaGammaOpen IntExpirationCurrent SpreadLast Price
2022-12-16 CALL at $1.00.90630.045202022-12-160.85 - 2.50.0In
2022-12-16 CALL at $2.00.81430.7839482022-12-160.25 - 0.350.3In
2022-12-16 PUT at $1.0-0.05870.078402022-12-160.0 - 0.050.05Out
2022-12-16 PUT at $2.0-0.20990.745362022-12-160.0 - 0.250.05Out
2022-12-16 PUT at $3.0-0.7620.4246192022-12-160.7 - 0.950.9In
2022-12-16 PUT at $4.0-0.71740.234902022-12-161.6 - 2.250.0In
2022-12-16 PUT at $5.0-0.76570.186602022-12-162.0 - 2.90.0In

Lexicon Pharmaceuticals Net Income Common Stock Over Time

The amount of net income (loss) for the period due to common shareholders. Typically differs from Net Income to the parent entity due to the deduction of Preferred Dividends.
   Net Income Common Stock   

Lexicon Pharmaceuticals Historical Liabilities

While analyzing the current debt level is an essential aspect of forecasting the current year budgeting needs of Lexicon Pharmaceuticals, understanding its historical liability is critical in projecting Lexicon Pharmaceuticals' future earnings, especially during periods of low and high inflation and deflation. Many analysts look at the trend in assets and liabilities and evaluate how Lexicon Pharmaceuticals uses its financing power over time.

Lexicon Pharmaceuticals Investors Sentiment

The influence of Lexicon Pharmaceuticals' investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Lexicon. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock markets does not have a solid backing from leading economists and market statisticians.
Investor biases related to Lexicon Pharmaceuticals' public news can be used to forecast risks associated with investment in Lexicon. The trend in average sentiment can be used to explain how an investor holding Lexicon can time the market purely based on public headlines and social activities around Lexicon Pharmaceuticals. Please note that most equiteis that are difficult to arbitrage are affected by market sentiment the most.
Lexicon Pharmaceuticals' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Lexicon Pharmaceuticals' and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Lexicon Pharmaceuticals' news discussions. The higher the estimated score, the more favorable is the investor's outlook on Lexicon Pharmaceuticals.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Lexicon Pharmaceuticals in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Lexicon Pharmaceuticals' short interest history, or implied volatility extrapolated from Lexicon Pharmaceuticals options trading.

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Lexicon Pharmaceuticals using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Additionally, see Correlation Analysis. You can also try Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.

Complementary Tools for analysis

When running Lexicon Pharmaceuticals price analysis, check to measure Lexicon Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lexicon Pharmaceuticals is operating at the current time. Most of Lexicon Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Lexicon Pharmaceuticals' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Lexicon Pharmaceuticals' price. Additionally, you may evaluate how the addition of Lexicon Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Commodity Channel Index
Use Commodity Channel Index to analyze current equity momentum
Focused Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Global Correlations
Find global opportunities by holding instruments from different markets
Is Lexicon Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Lexicon Pharmaceuticals. If investors know Lexicon will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Lexicon Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth YOY
Market Capitalization
426.5 M
Quarterly Revenue Growth YOY
Return On Assets
Return On Equity
The market value of Lexicon Pharmaceuticals is measured differently than its book value, which is the value of Lexicon that is recorded on the company's balance sheet. Investors also form their own opinion of Lexicon Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Lexicon Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Lexicon Pharmaceuticals' market value can be influenced by many factors that don't directly affect Lexicon Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Lexicon Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine Lexicon Pharmaceuticals value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Lexicon Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.